Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice

INTRODUCTION: Given their relative simplicity of manufacture and ability to be injected repeatedly, vaccines in a protein format are attractive for breast and other cancers. However, soluble human epidermal growth factor receptor (HER2)/neu protein as a vaccine has not been immunogenic. When protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bei, Zaidi, Neeha, He, Li-Zhen, Zhang, Li, Kuroiwa, Janelle MY, Keler, Tibor, Steinman, Ralph M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446373/
https://www.ncbi.nlm.nih.gov/pubmed/22397502
http://dx.doi.org/10.1186/bcr3135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446373/
https://www.ncbi.nlm.nih.gov/pubmed/22397502
http://dx.doi.org/10.1186/bcr3135

Ejemplares similares